Startseite>>Signaling Pathways>> Membrane Transporter/Ion Channel>> ATPase>>ATP synthase inhibitor 1

ATP synthase inhibitor 1

Katalog-Nr.GC35421

ATP-Synthase-Inhibitor 1 ist ein potenter Inhibitor der c-Untereinheit des F1/FO-ATP-Synthase-Komplexes, hemmt die Öffnung der mitochondrialen PermeabilitÄtsÜbergangsporen (mPTP) und beeinflusst die ATP-Spiegel nicht .

Products are for research use only. Not for human use. We do not sell to patients.

ATP synthase inhibitor 1 Chemische Struktur

Cas No.: 1023043-30-2

Größe Preis Lagerbestand Menge
5mg
144,00 $
Auf Lager
10mg
234,00 $
Auf Lager
50mg
747,00 $
Auf Lager
100mg
1.215,00 $
Auf Lager
100mg
1.669,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ATP synthase inhibitor 1 is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex, inhibits mitochondrial permeability transition pore (mPTP) opening, does not affect ATP levels[1]. F1/FO-ATP synthase[1]

ATP synthase inhibitor 1 (Compound 10) is a potent inhibitor of c subunit of the F1/FO-ATP synthase complex[1].

[1]. Morciano G, et al. Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. J Med Chem. 2018 Aug 23;61(16):7131-7143.

Bewertungen

Review for ATP synthase inhibitor 1

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ATP synthase inhibitor 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.